Effectiveness Of Osteopathic Manipulative Treatment In NICU: A Multicenter Clinical Trial
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The use of complementary and alternative medicine in neonatal ward has been steadily rising during the last decade. This integrated medicine approach has been shown to be helpful to improve neonatal health care. Osteopathic manipulative treatment (OMT) has been applied to premature infants to reduce the length of stay and to cope with clinical complications. Results from previous studies documented the positive association between OMT and shorter period of hospitalisation as well as improvement of clinical conditions. The aim of this nationwide multicenter study is to demonstrate the effect of OMT on length of stay (LOS) in premature infants across 3 neonatal intensive care units (NICU).
| Condition | Intervention |
|---|---|
|
Prematurity |
Other: osteopathic manipulative treatment Other: Usual care |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Effectiveness Of Osteopathic Manipulative Treatment In Neonatal Intensive Care Units: A Multicenter Randomized Clinical Trial |
- Number of days of LOS [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 4 weeks ] [ Designated as safety issue: No ]
- pre-post difference in weight gain [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 4 weeks ] [ Designated as safety issue: No ]
- number of episodes of vomit [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 4 weeks ] [ Designated as safety issue: No ]
- days to full enteral feeding [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 4 weeks ] [ Designated as safety issue: No ]
- NICU costs [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 4 weeks ] [ Designated as safety issue: No ]
- number of episodes of regurgitation [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 4 weeks ] [ Designated as safety issue: No ]
- number of episodes of stooling [ Time Frame: participants will be followed for the duration of hospital stay, an expected average of 4 weeks ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 690 |
| Study Start Date: | July 2012 |
| Estimated Study Completion Date: | June 2013 |
| Estimated Primary Completion Date: | April 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: OMT
patients under usual medical care plus osteopathic treatment
|
Other: osteopathic manipulative treatment
Patients from this group received osteopathic treatments twice a week for the entire length of stay in the unit.
|
|
control
patients under usual medical care
|
Other: Usual care
Patients from control group received standard care plus osteopathic evaluation only, according to the same schedule as the study group.
|
Eligibility| Ages Eligible for Study: | 29 Weeks to 37 Weeks |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- preterm infants born at age between 29 and 37 weeks
- osteopathic treatment performed < 14 days after birth
- preterms born in the same hospital
Exclusion Criteria:
- Gestational age < 29 weeks
- Gestational age > 37 weeks
- First OMT performed after 14 days from birth
- genetic disorders
- congenital disorders
- cardiovascular abnormalities
- proven or suspected necrotized enterocolitis with or without gastrointestinal perforation
- proven or suspected abdominal obstruction
- pre/post surgery patients
- pneumoperitoneum
- atelectasis
- Newborn from an HIV seropositive/drug addicted mother
- respiratory disorders
- transferred to/from other hospital
- admitted for preterminal comfort care (defined as neither intubation nor cardio-respiratory resuscitation)
Contacts and Locations| Contact: Francesco Cerritelli, DO, MS | +393394332801 | francesco.cerritelli@ebom.it |
| Italy | |
| Monza Hospital | Recruiting |
| Monza, Lombardia, Italy, 20052 | |
| Macerata Hospital | Recruiting |
| Macerata, Marche, Italy, 62100 | |
| Sub-Investigator: Alessandro Accorsi, DO, BSN | |
| Pescara hospital | Recruiting |
| Pescara, Italy, 65121 | |
| Principal Investigator: Francesco Cerritelli, DO, MS | |
More Information
Additional Information:
No publications provided
| Responsible Party: | European Institute for Evidence Based Osteopathic Medicine |
| ClinicalTrials.gov Identifier: | NCT01645137 History of Changes |
| Other Study ID Numbers: | Multi-NE-O |
| Study First Received: | July 15, 2012 |
| Last Updated: | February 4, 2013 |
| Health Authority: | Italy: Ethics Committee |
Keywords provided by European Institute for Evidence Based Osteopathic Medicine:
|
prematurity OMT complementary and alternative medicine neonates length of stay |
ClinicalTrials.gov processed this record on May 23, 2013